To identify the main differences in treatment between the 'protected' group and the 'unprotected' group based on the process variants provided, we need to look at several aspects: frequency, performance (in terms of time taken), and the sequence of steps in the treatment process. Here are some observations and potential differences:

1. **Frequency of processes:**
   - The 'protected' group has a wider variety of process variants, suggesting a more personalized or less standardized approach to treatment. This could mean that each patient in the protected group may be receiving a more tailored treatment plan.
   - The 'unprotected' group has higher frequencies for certain process variants, such as the Expert Examination -> Thorough Examination -> Diagnosis -> Treatment -> Treatment successful -> Discharge path, indicating a more streamlined or commonly followed process for this subset of patients.

2. **Performance (Time taken):**
   - The 'unprotected' group generally shows faster performance times, with several variants completing treatment in under 33 days (e.g., 220004.479 to 320004.432 days for completion).
   - The 'protected' group has longer performance times, with many variants taking over 33 days to complete (e.g., 260001.236 to 320008.950 days for completion).
   - The longest treatment times in the 'protected' group (around 32 or 33 days) are still longer than the shortest treatment times in the 'unprotected' group.

3. **Treatment outcomes:**
   - Both groups have a mix of successful and unsuccessful treatment outcomes, but the 'protected' group has a higher frequency of 'Treatment unsuccessful' -> 'Diagnosis' -> 'Treatment' -> 'Treatment successful' -> 'Discharge' sequences, followed by additional successful treatments or discharges.
   - The 'unprotected' group also has 'Treatment unsuccessful' sequences but seems to recover from these and succeed in subsequent treatments more frequently than the 'protected' group.

4. **Diagnostic intensity:**
   - The 'protected' group has higher frequency of variants involving 'Expert Examination' and 'Thorough Examination', suggesting a higher level of diagnostic scrutiny.
   - The 'unprotected' group has a higher frequency of 'Diagnosis' directly following 'Thorough Examination' or 'Expert Examination' without the intervening step of 'Expert Examination', indicating possibly less intensive diagnostic processes.

5. **Treatment interruptions:**
   - The 'protected' group has instances of 'Treatment unsuccessful' followed by additional diagnoses and treatments without discharge, suggesting more complex or ongoing treatment challenges.
   - The 'unprotected' group also encounters 'Treatment unsuccessful' scenarios but seems to resolve them faster and move on to successful treatment outcomes or discharge.

In summary, the main differences between the 'protected' and 'unprotected' groups appear to be in the treatment duration (with the 'unprotected' group experiencing faster treatment times) and the diagnostic intensity (with the 'protected' group undergoing more intensive examinations). The 'unprotected' group also seems to successfully navigate and resolve treatment interruptions more efficiently than the 'protected' group.

To address potential unfairness, one would need to investigate the reasons behind these differences. It could be due to various factors such as different treatment protocols, resource allocation, patient health status, or even systemic biases. A thorough analysis of each case, considering individual patient characteristics and the medical necessity for each treatment step, would be necessary to pinpoint the cause of any unfair treatment differences.